Risk of incident gout and major adverse cardiovascular events according to angiotensin receptor blocker type in amlodipine-based combination therapy: a nationwide cohort study

28 August 2026 (09:15 - 09:40)
Organised by: Logo
Congress Presentation Part of: Contemporary pharmacotherapy for hypertension Angiotensin-Renin-Bradykinin System ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology